KITD816V+ systemic mastocytosis associated with KIT D816V+ acute erythroid leukaemia: First case report with molecular evidence for same progenitor cell derivation

Journal of Clinical Pathology

Volumn 62, Issue 12, 2009, Pages 1147-1149

  McClintock Treep, S A ^a   Horny, H P ^b   Sotlar, K ^c   Foucar, M K ^a   Reichard, K K ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Klinikum Ansbach   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; STEM CELL FACTOR;

ACUTE ERYTHROID LEUKAEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN TISSUE; MAST CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; STEM CELL; SYSTEMIC MASTOCYTOSIS;

FATAL OUTCOME; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; MUTATION; NEOPLASTIC STEM CELLS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 73449109550     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.067876     Document Type: Article

References (9)

1. Sotlar K, Bache A, Stellmacher F, et al. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008;10:58-66.
2. Sotlar K, Escribano L, Landt O, et al. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 2003;162:737-46.
3. D816V. Leuk Res 2009;33:735-41.
4. Horny H-P, Metcalfe DD, Bennett JM, et al. Mastocytosis. In: Tumours of haematopoietic and lymphoid tissues (WHO). Lyon, France: IARC Press, 2008:54-63.
5. Sperr WR, Horny H-P, Lechner K, et al. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma 2000;37:473-86.
6. Pullarkat ST, Sedarat F, Paquette R, et al. Systemic mastocytosis with plasma cell dyscrasia: report of a case. Leuk Res 2008;32:1160-3.
7. Horny H-P, Sotlar K, Stellmacher F, et al. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). J Clin Pathol 2006;59:264-8.
8. Tzankov A, Sotlar K, Muhlematter D, et al. Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3. J Clin Pathol 2008;61:958-61.
9. Frost MJ, Ferrao PT, Hughes TP, et al. Juxtamembrane mutant V560GKit is more sensitive to imatinib (STI571) compared with wild-type c-KIT whereas the kinase domain mutant D816V Kit is resistant. Mol Cancer Ther 2002;1:1115-24.